Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study. [electronic resource]
Producer: 20110929Description: 346-53 p. digitalISSN:- 1476-5527
- Adiponectin -- blood
- Adult
- Aged
- Amlodipine -- pharmacology
- Antihypertensive Agents -- pharmacology
- Blood Pressure -- drug effects
- C-Reactive Protein -- metabolism
- Comorbidity
- Cytokines -- blood
- Diabetes Mellitus, Type 2
- Drug Therapy, Combination
- Female
- Humans
- Hydrochlorothiazide -- pharmacology
- Hypertension -- blood
- Imidazoles -- pharmacology
- Incidence
- Insulin Resistance -- physiology
- Intercellular Adhesion Molecule-1 -- blood
- Male
- Metabolic Syndrome -- blood
- Middle Aged
- Prospective Studies
- Single-Blind Method
- Tetrazoles -- pharmacology
- Treatment Outcome
- Vascular Cell Adhesion Molecule-1 -- blood
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.